NCT06955533View on ClinicalTrials.gov

Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
Stent Related Symptoms
Interventions
DRUG

Double dose tamsulosin and solifenacin

Odd number

DRUG

Single dose tamsulosin and solifenacin

Even number

Trial Locations (1)

Unknown

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06955533 - Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms | Biotech Hunter | Biotech Hunter